Patient Monitoring Devices are used to observe, measure, and record vital signs in patients. Sleep Apnea Diagnostic Systems include systems and devices used for the diagnosis of sleep apnea. GlobalData uses proprietary data and analytics to provide a comprehensive report on the sleep apnea diagnostic systems market in the UK. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the sleep apnea diagnostic systems market in the UK was ResMed followed by Somnomedics, Natus Medical, Koninklijke Philips, Heinen + Lowenstein, Cadwell Industries and Nihon Kohden.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
Sleep Apnea Diagnostic Systems include Polysomnography Systems (PSG systems) used for the screening of sleep apnea. One PSG system includes amplifiers, hard disk, monitor, recorder, laser printer, electrodes, cables, stands, stimulators, chest and abdomen respiration belt and sensors. Fixed and Portable Polysomnography systems are tracked under this. Sleep Apnea is a common sleeping disorder that breaks breath many times during sleep. Obstructive Sleep Apnea (OSA) is the most common type of sleep apnea; it causes snoring when the soft tissue in the back of the throat relaxes during sleep and blocks the airway. Polysomnogram is the most common sleep study for diagnosing OSA. This study records brain activity, eye movements, heart rate, and blood pressure.
The sleep apnea diagnostic systems market in the UK can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size sleep apnea diagnostic systems in the UK, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.
